Christine Desmedt

Christine Desmedt received the Bio-engineering degree in cells and genes biotechnology from the Catholic University of Leuven, Leuven, Belgium, in 2000, In 2004, the Master's degree in bio-medical sciences at the Free University of Brussels, Brussels, Belgium, and the Ph.D. degree from the Breast Cancer Translational Research Laboratory, Jules Bordet Institute, headed by C. Sotiriou, where she started a Ph.D. entitled “Multimarker approach for improving breast cancer treatment tailoring” in 2008. Since 2000, she has been with the Jules Bordet Institute, an autonomous comprehensive cancer center devoted entirely to the fight against cancer. For two years, she was a Clinical Monitor for the Breast European Adjuvant Studies Group (Br.E.A.S.T), cocoordinating the monitoring activities of external groups for the conduct of breast cancer trials. Since then, besides conducting research projects, she is also assisting the head of the lab in the scientific and administrative management of the lab. Her projects involve identification and validation of prognostic and predictive markers in breast cancer, as well as a better characterization of breast cancer development and metastasis. She received grants from the MEDIC Foundation, the “Fonds National de la Recherche Scientifique”, the Fondation Lambeau-Marteau, and the Fonds Heuson. She is also actively involved in several EU-projects. Dr. Desmedt has received awards from the AACR and ASCO.